May 23, 2017
Recommended Topic Related To:


"Dec. 5, 2012 -- A breath test similar to the one used to determine when a driver has had too much to drink shows promise as a screening tool for cancer.

In a new study from Italy, researchers were able to identify patients with colorectal c"...



Vectibix Patient Information including How Should I Take

What should I discuss with my health care provider before receiving panitumumab (Vectibix)?

This medication may cause severe skin problems such as acne, itching, redness, skin rash, dryness, peeling, cracking, or oozing, and swelling or infection around your fingernails or toenails. More severe forms of skin problems can lead to widespread infection and possibly death. Seek emergency medical attention at the first sign of any skin rash.

You should not use panitumumab if you are allergic to it.

Before you receive this medication, you may need to undergo a biopsy to make sure panitumumab is the right medication to treat your cancer.

To make sure panitumumab is safe for you, tell your doctor if you have any of these conditions:

  • allergies or breathing problems;
  • an ulcer on the cornea of your eye (keratitis); or
  • an electrolyte imbalance (such as low levels of calcium or magnesium in your blood).

FDA pregnancy category C. It is not known whether panitumumab will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.

Use birth control to prevent pregnancy while you are receiving panitumumab, whether you are a man or a woman. Panitumumab use by either parent may cause birth defects. Continue using birth control for 6 months after you stop receiving this medication.

It is not known whether panitumumab passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are using panitumumab.

You may have irregular menstrual periods while receiving panitumumab.

How is panitumumab given (Vectibix)?

Panitumumab is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. Panitumumab must be given slowly, and the IV infusion can take up to 90 minutes to complete.

Panitumumab is usually given once every 2 weeks. Follow your doctor's instructions.

To be sure this medication is not causing harmful effects, your blood may need to be tested often. Panitumumab can have long lasting effects on your body. Do not miss any follow up visits to your doctor, which may include at least 8 weeks after you stop using panitumumab.

Side Effects Centers

Vectibix - User Reviews

Vectibix User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Vectibix sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Get the latest treatment options.